Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma.
N Engl J Med. 2017 Mar 16;376(11):1015-1026. doi: 10.1056/NEJMoa1613683. Epub 2017 Feb 17.
N Engl J Med. 2017.
PMID: 28212060
Free PMC article.
Clinical Trial.